{"pmid":32373999,"title":"Coronavirus disease 2019: a clinical review.","text":["Coronavirus disease 2019: a clinical review.","In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, and it subsequently spread in many countries around the world. Many efforts have been applied to control and prevent the spread of COVID-19, and many scientific studies have been conducted in a short period of time. Here we present an overview of the viral structure, pathogenesis, diagnosis, and clinical features of COVID-19 based on the current state of knowledge, and we compare its clinical characteristics with SARS and Middle East Respiratory Syndrome (MERS). Current researches on potentially effective treatment alternatives are discussed. We hope this review can help medical workers and researchers around the world contain the current COVID-19 pandemic.","Eur Rev Med Pharmacol Sci","Yang, C-L","Qiu, X","Zeng, Y-K","Jiang, M","Fan, H-R","Zhang, Z-M","32373999"],"abstract":["In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, and it subsequently spread in many countries around the world. Many efforts have been applied to control and prevent the spread of COVID-19, and many scientific studies have been conducted in a short period of time. Here we present an overview of the viral structure, pathogenesis, diagnosis, and clinical features of COVID-19 based on the current state of knowledge, and we compare its clinical characteristics with SARS and Middle East Respiratory Syndrome (MERS). Current researches on potentially effective treatment alternatives are discussed. We hope this review can help medical workers and researchers around the world contain the current COVID-19 pandemic."],"journal":"Eur Rev Med Pharmacol Sci","authors":["Yang, C-L","Qiu, X","Zeng, Y-K","Jiang, M","Fan, H-R","Zhang, Z-M"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32373999","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.26355/eurrev_202004_21045","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666138496309395457,"score":9.490897,"similar":[{"pmid":32245083,"pmcid":"PMC7157541","title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["covid-19","coronavirus","sars","sars-cov-2","wuhan","pandemic"],"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1666138492019671040,"score":157.46979},{"pmid":32112977,"pmcid":"PMC7105032","title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","text":["World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).","An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.","Int J Surg","Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz","32112977"],"abstract":["An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19."],"journal":"Int J Surg","authors":["Sohrabi, Catrin","Alsafi, Zaid","O'Neill, Niamh","Khan, Mehdi","Kerwan, Ahmed","Al-Jabir, Ahmed","Iosifidis, Christos","Agha, Riaz"],"date":"2020-03-01T11:00:00Z","year":2020,"_id":"32112977","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.ijsu.2020.02.034","keywords":["covid-19","global health emergency","novel coronavirus","viral transmission","wuhan"],"link_erratum_in":"32305321","link_comment_in":"32169574","locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1666138490760331264,"score":146.52647},{"pmid":32448490,"title":"Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV.","text":["Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV.","At the end of the year 2019, the novel coronavirus (2019-nCoV) was spreading in Wuhan, China, and the outbreak process has a high speed. It was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Coronaviruses are enveloped and single-stranded RNA that have several families including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The pathogenesis mechanism and disease outcomes of SARS and MERS are now clear to some extent, but little information is available for 2019-nCoV. This newly identified corona virus infection represents flu-like symptoms, but usually the first symptoms are fever and dry cough. There has been no specific treatment against 2019-nCoV up to now, and physicians only apply supportive therapy. In the present article, we made an attempt to review the behavior of the virus around the world, epidemiology, a pathway for influx into the host cells, clinical presentation, as well as the treatments currently in use and future approaches; nitazoxanide may be our dream drug. We hope that this review has a positive impact on public knowledge for helping to deal with the 2019-nCoV and move one step forward toward its treatment in the near future.","Arch Med Res","Hemmati, Farshad","Saedi, Samira","Hemmati-Dinarvand, Mohsen","Zarei, Marzie","Seghatoleslam, Atefeh","32448490"],"abstract":["At the end of the year 2019, the novel coronavirus (2019-nCoV) was spreading in Wuhan, China, and the outbreak process has a high speed. It was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Coronaviruses are enveloped and single-stranded RNA that have several families including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The pathogenesis mechanism and disease outcomes of SARS and MERS are now clear to some extent, but little information is available for 2019-nCoV. This newly identified corona virus infection represents flu-like symptoms, but usually the first symptoms are fever and dry cough. There has been no specific treatment against 2019-nCoV up to now, and physicians only apply supportive therapy. In the present article, we made an attempt to review the behavior of the virus around the world, epidemiology, a pathway for influx into the host cells, clinical presentation, as well as the treatments currently in use and future approaches; nitazoxanide may be our dream drug. We hope that this review has a positive impact on public knowledge for helping to deal with the 2019-nCoV and move one step forward toward its treatment in the near future."],"journal":"Arch Med Res","authors":["Hemmati, Farshad","Saedi, Samira","Hemmati-Dinarvand, Mohsen","Zarei, Marzie","Seghatoleslam, Atefeh"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448490","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.arcmed.2020.04.022","keywords":["2019-ncov","infection","novel coronavirus","respiratory problem","treatment approach"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["nitazoxanide"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213914120193,"score":141.43268},{"pmid":32282863,"pmcid":"PMC7104082","title":"Molecular immune pathogenesis and diagnosis of COVID-19.","text":["Molecular immune pathogenesis and diagnosis of COVID-19.","Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.","J Pharm Anal","Li, Xiaowei","Geng, Manman","Peng, Yizhao","Meng, Liesu","Lu, Shemin","32282863"],"abstract":["Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection."],"journal":"J Pharm Anal","authors":["Li, Xiaowei","Geng, Manman","Peng, Yizhao","Meng, Liesu","Lu, Shemin"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282863","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jpha.2020.03.001","keywords":["coronavirus","mers-cov","pathogenesis","sars-cov","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138491412545538,"score":140.65753},{"pmid":32374000,"title":"An update on the status of COVID-19: a comprehensive review.","text":["An update on the status of COVID-19: a comprehensive review.","The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).","Eur Rev Med Pharmacol Sci","Zhao, N","Zhou, Z-L","Wu, L","Zhang, X-D","Han, S-B","Bao, H-J","Shu, Y","Shu, X-G","32374000"],"abstract":["The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19)."],"journal":"Eur Rev Med Pharmacol Sci","authors":["Zhao, N","Zhou, Z-L","Wu, L","Zhang, X-D","Han, S-B","Bao, H-J","Shu, Y","Shu, X-G"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374000","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.26355/eurrev_202004_21046","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138496315686912,"score":140.60925}]}